|
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg
|
|
32
|
782
|
1 July 2024
|
|
VIR-3434 Phase 1-study made by Vir Biotechnology
|
|
28
|
2729
|
21 December 2023
|
|
NMN supplement investigated as a potential cure - “Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B”
|
|
14
|
1434
|
19 August 2023
|
|
SCG Cell Therapy to Present Late-Breaking Data
|
|
10
|
803
|
8 June 2023
|
|
Advocating for people with hepatitis B to be included in COVID-19 clinical trials
|
|
1
|
699
|
11 March 2021
|
|
Invitation to Apply - Global Hepatitis B and D Community Advisory Boards
|
|
0
|
541
|
28 March 2022
|
|
Is mRNA vaccine the answer?
|
|
2
|
963
|
14 January 2023
|
|
Lived Experience Treatment Preferences Survey
|
|
1
|
472
|
8 March 2023
|
|
HerberNasvac Therapeutic Vaccine
|
|
3
|
1166
|
19 January 2023
|
|
Invitation to Participate in Survey on Hepatitis B Knowledge and Stigma
|
|
0
|
683
|
5 June 2021
|
|
Exploratory Hepatitis B dataset: Encouraging new hypotheses
|
|
4
|
422
|
31 March 2024
|
|
Community program in hepatitis
|
|
4
|
697
|
3 September 2022
|
|
Nucs off functional cure
|
|
1
|
578
|
4 April 2023
|
|
Call for stories
|
|
0
|
449
|
1 April 2022
|
|
Hepatitis B virus genetic diversity predicts potential to achieve functional cure
|
|
1
|
852
|
4 December 2022
|
|
Discovery of a first-in-class orally available HBV cccDNA inhibitor
|
|
4
|
677
|
4 April 2023
|
|
Arbutus - AB-729 rnai, phase2 results
|
|
1
|
428
|
23 June 2023
|
|
Searchable database of HBV trials in Australia
|
|
4
|
838
|
21 June 2021
|
|
GIGA-2339 polyclonal antibody treatment
|
|
4
|
745
|
28 July 2023
|
|
HBIG clinical trial in Germany for CHB
|
|
5
|
664
|
9 March 2023
|
|
Paid research participation - interview with people living with hep B
|
|
0
|
470
|
18 January 2023
|
|
ASHM Stigma and Discrimination Video Project
|
|
0
|
398
|
31 August 2022
|
|
New to this need some help
|
|
3
|
566
|
17 September 2022
|
|
Call for research participants ($50 reimbursement for time)
|
|
6
|
688
|
23 February 2023
|
|
Tenofovir amibufenamide vs Vemlidy
|
|
5
|
730
|
18 April 2024
|
|
(CLOSED) Survey for Australians living with HBV in NSW
|
|
2
|
1021
|
29 December 2020
|
|
HepBFoundation Clinical Trials Finder
|
|
0
|
313
|
8 June 2023
|
|
Study of social media messages to promote hepatitis B testing and connection to care among the Vietnamese community in NSW
|
|
1
|
622
|
26 October 2022
|
|
Vaccitech - HBV002 Study
|
|
4
|
581
|
24 June 2023
|
|
Recent HBV studies
|
|
8
|
426
|
7 January 2024
|
|
Community & Lived Experience Scholarships for VH2024
|
|
3
|
278
|
5 March 2024
|
|
New treatment of HepB maybe ? AGT
|
|
2
|
560
|
31 July 2023
|
|
Brii Bio results
|
|
2
|
395
|
27 June 2023
|
|
Hep B and immunity study - call for participants ($50 reimbursement)
|
|
0
|
434
|
2 February 2023
|
|
Evaluation of Hepatitis B Virus (HBV) DNA Test as Point of Care Tool (HBVPOCT)
|
|
0
|
424
|
24 April 2023
|
|
Are you working on HBV in a resource limited setting? Please answer this survey
|
|
0
|
419
|
1 July 2022
|
|
Health & Law Project
|
|
1
|
193
|
9 March 2024
|
|
Position Available: Viral Hepatitis Peer Worker (Lived Experience)
|
|
0
|
202
|
2 April 2024
|
|
VH2024: Abstract & Scholarship Opportunities
|
|
0
|
165
|
11 March 2024
|
|
Positions Available at Hepatitis NSW
|
|
0
|
152
|
23 February 2024
|